To facilitate preclinical and clinical translation of IL10-based therapeutics for ischemic heart disease, in this study, we addressed the knowledge gap between the therapeutic dosage of IL-10, immune modulation, cardiac repair, and possible unwanted effects. This evidence concerns the gene IL10 and coronary artery disorder.